Brainomix

Brainomix is a private medical technology company founded in 2010 as a spin-out from the University of Oxford. The company specializes in developing AI-powered imaging biomarkers aimed at enhancing clinical decision-making and improving patient outcomes across various medical conditions, particularly in stroke, lung cancer, and pulmonary diseases. Their solutions aim to improve diagnosis, patient outcomes, and clinical trial success by leveraging advanced AI in medical imaging.